ClinicalTrials.gg
RecruitingNCT07302204Updated Jun 25, 2026

Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis

An interventional study of Aerobic Exercise and Therapeutic Exercise in Osteoarthritis of the Knee, sponsored by University of Nove de Julho. Recruiting at 2 sites in Brazil. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by University of Nove de Julho · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 79 studies in Osteoarthritis, Knee with a site in Brazil — 12 open to participants now, 13 under way, 2 of them phase 3. Osteoarthritis, Knee · Brazil.

Planned enrollment
30th of 77
90 · median 70
Started
2026
with 1 other
No phase
50 of 79
9 open now
Primary completion
2029-12
later than 11 of 12 live
Registered
77th of 79
by date
Lead sponsor
8 of 79
University of Nove de Julho

Among the 79 studies in Osteoarthritis, Knee with a site in Brazil, this one is the 30th largest by planned enrollment of the 77 interventional ones that give a count, is one of 2 that started in 2026, is one of 50 with no phase, reaches primary completion later than 11 of the 12 other live ones, and was the 77th registered.

Osteoarthritis, Knee

3,292 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 79 studies in Osteoarthritis, Knee with a site in Brazil are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 382 Osteoarthritis, Knee studies recruiting now, 176 (46%) set no upper age limit and 113 (30%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 40 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Osteoarthritis, Knee with a site in Brazil, or all of them as a file.
02

Study summary

The study compares two exercise strategies in people with knee osteoarthritis. The first is aerobic exercise on a recumbent cycle ergometer, with effort controlled by the Borg scale. The second is a therapeutic exercise program with resistance, neuromuscular, mobility, and balance components. The primary objective is to determine which approach produces greater exercise induced hypoalgesia, measured by the increase in pressure pain threshold at the knee within the session across four anchor sessions during a ten week program. This is a randomized clinical trial with two parallel arms. Ninety participants, between forty five and seventy five years of age, will be allocated to one of the two groups. Allocation sequence concealment will be ensured using opaque envelopes. The outcome assessor will remain blinded to group allocation. The interventions will take place three times per week for ten weeks. Assessments will be performed at baseline and after ten weeks. Within session measurements will also be taken in weeks one, four, seven, and ten. The primary outcome is the intra session change in pressure pain threshold at the medial compartment of the knee. Secondary outcomes include exercise induced hypoalgesia in the quadriceps and trapezius, chronic adaptation of pressure pain threshold, conditioned pain modulation, pain intensity, pain self efficacy, knee related health status, functional performance, quadriceps strength, global perceived effect, and adherence. The planned sample size is forty five participants per group. The analysis will follow the intention to treat principle. The primary outcome will be compared using linear mixed models with group and time effects. Clinical outcomes at T1 will be adjusted for baseline values. Estimates, confidence intervals, and interpretation in light of minimally important differences will be reported.

03

Conditions studied

  • Osteoarthritis of the Knee
04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of symptomatic knee osteoarthritis for at least 3 months.
  • Report of knee pain for more than 3 months and average knee pain intensity ≥ 3 on the 0 to 10 Numeric Rating Scale.
  • Morning stiffness lasting less than 30 minutes.
  • Clinical signs compatible with knee osteoarthritis. crepitus, bony tenderness and absence of palpable warmth at the knee.
  • Altered exercise-induced hypoalgesia: absence of exercise-induced hypoalgesia and hyperalgesic response to exercise.

Exclusion criteria

Exclusion Criteria:

  • Signs and symptoms indicating the hip as the main source of pain.
  • Osteoporosis
  • Fibromyalgia
  • History of tumors or cancer
  • Active inflammatory joint diseases, such as rheumatoid arthritis or gout.
  • Previous arthroplasty of any lower limb joint.
  • Neurological diseases, including Parkinson's disease, stroke, multiple sclerosis, muscular dystrophy, motor neuron disease or Alzheimer's disease.
  • Cardiovascular diseases for which exercise is formally .
  • Infected wounds or osteomyelitis in the knee region.
  • Deep vein thrombosis or thrombophlebitis.
  • Sensory alterations in the lower limbs.
  • Cognitive or cardiopulmonary impairments that limit safe participation in the exercise program.
  • Use of walking aids.
  • Recent knee trauma.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Aerobic Exercise Group (AEG)

    Participants allocated to the Aerobic Exercise Group (AEG) will perform supervised cycling on an electromagnetic recumbent stationary bicycle three times per week for ten weeks, with at least 24 hours between sessions. Each session will be structured as five minutes of warm up, a progressively longer work phase, and five minutes of cool down. Exercise intensity will be prescribed and monitored using the 6 to 20 Borg Rating of Perceived Exertion scale, targeting light to moderate exertion during warm up and cool down and moderate to somewhat hard exertion during the work phase. Cadence will be maintained around 60 to 80 revolutions per minute and the resistance level will be adjusted to keep participants within the target exertion zone.

    Other: Aerobic Exercise

  • Active comparator
    Therapeutic Exercise Group (TEG)

    Participants allocated to the Therapeutic Exercise Group will receive an individually supervised, land based therapeutic exercise program focusing on warm up, resisted strengthening, neuromuscular training, mobility and balance. Sessions will be performed three times per week for ten weeks, with at least 24 hours between sessions, and will last approximately 60 minutes. Therapeutic exercises will be completed in up to three sets of 8 to 12 repetitions in weeks 1 to 5 and 8 to 15 repetitions in weeks 6 to 10, each set lasting 30 to 60 seconds, with 90 second rest intervals between sets. Load for machine or free weight exercises will be prescribed at about 40 to 60 percent of the pain limited one repetition maximum, elastic band resistance will be set to allow 12 repetitions with pain ≤ 5 out of 10, and body weight exercises will be held for 30 to 60 seconds. Vital signs and knee pain intensity will be assessed before, during and after each session to guide safety and progression.

    Other: Therapeutic Exercise

Interventions

  • OtherAerobic Exercise

    Supervised cycling on an electromagnetic recumbent stationary bicycle three times per week for ten weeks, with at least 24 hours between sessions.

  • OtherTherapeutic Exercise

    Individually supervised, land based therapeutic exercise program focusing on warm up, resisted strengthening, neuromuscular training, mobility and balance.

06

What researchers measure

Primary outcomes

  1. Exercise-induced hypoalgesia (EIH)

    exercise induced hypoalgesia (EIH) of the medial compartment of the knees, measured by the change in pressure pain threshold (Δ PPT)

    Time frame: At weeks 1, 4, 7, and 10 of the 10 week intervention (within session, pre and immediately post exercise).

Secondary outcomes

  1. Exercise induced hypoalgesia of the quadriceps

    Within session change in pressure pain threshold at the rectus femoris muscle, calculated as post exercise minus pre exercise values and averaged bilaterally, measured with a digital algometer and expressed in kilograms force per square centimeter.

    Time frame: Within session, immediately before and immediately after the exercise session at weeks 1, 4, 7, and 10 of the 10 week intervention.

  2. Exercise induced hypoalgesia of the upper trapezius

    Within session change in pressure pain threshold at the upper trapezius muscle descending portion, calculated as post exercise minus pre exercise values and averaged bilaterally, measured with a digital algometer and expressed in kilograms force per square centimeter.

    Time frame: Within session, immediately before and immediately after the exercise session at weeks 1, 4, 7, and 10 of the 10 week intervention.

  3. Chronic adaptation of pressure pain threshold

    Change in pressure pain threshold at the medial compartment of the knee, rectus femoris and upper trapezius between baseline and post intervention, averaged bilaterally and expressed in kilograms force per square centimeter.

    Time frame: Baseline and after 10 weeks of intervention.

  4. Conditioned pain modulation

    Change in the conditioned pain modulation effect assessed by a standardized conditioned pain modulation test, defined as the change in pressure pain threshold at the volar forearm during and after an ischemic conditioning stimulus on the contralateral arm, with pain intensity standardized around four out of ten on a numeric rating scale.

    Time frame: Baseline and after 10 weeks of intervention.

  5. Pain intensity

    Average knee pain intensity over the past seven days at rest and after movement, measured on an eleven-point numeric rating scale from zero (no pain) to ten (worst imaginable pain). Numeric Rating Scale for Pain Intensity. Range 0 to 10, with 0 indicating no pain and 10 the worst pain imaginable. Higher scores indicate greater pain intensity.

    Time frame: Baseline and after 10 weeks of intervention.

  6. Pain self efficacy

    Pain Self Efficacy Questionnaire. Ten items scored 0 to 6 each, total score 0 to 60. Higher scores indicate better outcome, greater pain related self efficacy.

    Time frame: Baseline and after 10 weeks of intervention.

  7. Knee related health status

    Knee Injury and Osteoarthritis Outcome Score. Subscales are transformed to a 0 to 100 score, where 0 represents the worst knee health status and 100 the best. Higher scores indicate better outcome, better knee related health status.

    Time frame: Baseline and after 10 weeks of intervention.

  8. Patient specific functional status

    Patient Specific Functional Scale. Each selected activity is rated from 0 to 10, where 0 means unable to perform the activity and 10 means able to perform as before the problem. The total score is the mean of the three activities, range 0 to 10. Higher scores indicate better outcome, better patient specific functional status.

    Time frame: Baseline and after 10 weeks of intervention.

  9. Functional performance, thirty second sit to stand test

    Number of full sit to stand repetitions completed from a standard height chair in thirty seconds, higher counts reflecting better lower limb strength, dynamic balance and functional performance.

    Time frame: Baseline and after 10 weeks of intervention.

  10. Quadriceps muscle strength

    Maximal voluntary isometric contraction of the quadriceps measured with a handheld dynamometer in a standardized seated position, normalized to body mass and expressed as a percentage, with higher values indicating greater strength.

    Time frame: Baseline and after 10 weeks of intervention.

  11. Global perceived effect

    Global Perceived Effect scale. Eleven point scale ranging from minus 5, much worse, to 0, no change, to plus 5, completely recovered. Higher scores indicate better outcome, greater perceived recovery.

    Time frame: After 10 weeks of intervention.

  12. Adherence to the intervention

    Proportion of attended exercise sessions relative to the thirty planned sessions, calculated as attendance percentage sessions attended divided by sessions planned multiplied by one hundred.

    Time frame: Throughout the 10 week intervention period.

  13. Physical activity enjoyment

    Perceived enjoyment during physical activity or exercise, assessed using the Brazilian Portuguese version of the Physical Activity Enjoyment Scale (PACES). The PACES includes 18 items answered on a 7 point bipolar scale, in which participants indicate how they felt about the exercise session just completed. Scores will be calculated according to the item recoding instructions of the instrument, with higher scores indicating greater perceived enjoyment of physical activity.

    Time frame: After 10 weeks of intervention.

07

Study locations

1 of 2 sites recruiting
  • Cid André Fidelis de Paula Gomes
    São Paulo, 01415000, Brazil
    Not yet recruiting
  • Nove de Julho University
    São Paulo, 01504-001, Brazil
    Recruiting
    • Cid Gomes · Contact
    • Cid Gomes, Phd · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2029, 46 months after the start.

Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 46 months is above that.

Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Dec 24, 2025
StartActual
Feb 20, 2026
Primary completionEst.
Dec 20, 2029
CompletionEst.
Dec 20, 2029
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07302204
Responsible party
Cid André Fidelis de Paula Gomes (Professor Phd, University of Nove de Julho) — Principal investigator
First posted
Dec 24, 2025
Start date
Feb 20, 2026
Primary completion
Dec 20, 2029 (estimated)
Completion
Dec 20, 2029 (estimated)
Last update
Jun 25, 2026

Study contacts

Cid Gomes, Phd
Contact
cid.andre@gmail.com
+5511970941936

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion